[go: up one dir, main page]

DE69325695D1 - Protein und Gen des Glutamatrezeptors - Google Patents

Protein und Gen des Glutamatrezeptors

Info

Publication number
DE69325695D1
DE69325695D1 DE69325695T DE69325695T DE69325695D1 DE 69325695 D1 DE69325695 D1 DE 69325695D1 DE 69325695 T DE69325695 T DE 69325695T DE 69325695 T DE69325695 T DE 69325695T DE 69325695 D1 DE69325695 D1 DE 69325695D1
Authority
DE
Germany
Prior art keywords
gene
protein
glutamate receptor
glutamate
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69325695T
Other languages
English (en)
Other versions
DE69325695T2 (de
Inventor
Masayoshi Mishina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chemical Corp filed Critical Mitsubishi Chemical Corp
Publication of DE69325695D1 publication Critical patent/DE69325695D1/de
Application granted granted Critical
Publication of DE69325695T2 publication Critical patent/DE69325695T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69325695T 1992-11-13 1993-11-11 Protein und Gen des Glutamatrezeptors Expired - Lifetime DE69325695T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30387892A JP3353841B2 (ja) 1992-11-13 1992-11-13 新規なタンパク質およびそれをコードする遺伝子

Publications (2)

Publication Number Publication Date
DE69325695D1 true DE69325695D1 (de) 1999-08-26
DE69325695T2 DE69325695T2 (de) 2000-03-09

Family

ID=17926365

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69325695T Expired - Lifetime DE69325695T2 (de) 1992-11-13 1993-11-11 Protein und Gen des Glutamatrezeptors

Country Status (3)

Country Link
EP (1) EP0600278B1 (de)
JP (1) JP3353841B2 (de)
DE (1) DE69325695T2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869609A (en) * 1990-12-12 1999-02-09 Zymogenetics, Inc. G protein coupled glutamate receptors
NZ240921A (en) * 1990-12-12 1994-06-27 Zymogenetics Inc G protein coupled glutamate receptor (neurotransmitters), recombinant production
DE69431432T2 (de) 1993-04-20 2003-04-24 Merck & Co., Inc. Untereinheiten von menschlichen n-methyl-d-aspartat rezeptoren, diese kodierende nukleinsäure und dessen verwendung
US6274330B1 (en) * 1993-12-30 2001-08-14 Zymogenetics, Inc. L-AP4 sensitive glutamate receptors
WO2002088182A1 (fr) * 2001-04-27 2002-11-07 Takeda Chemical Industries, Ltd. Nouvelle proteine des recepteurs couples aux proteines-g et adn associe
KR100509803B1 (ko) * 2002-10-23 2005-08-23 재단법인서울대학교산학협력재단 시냅스 가소성 저해활성을 가지는 단백질

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3149133B2 (ja) * 1989-10-27 2001-03-26 ザ ソーク インスティチュート フォア バイオロジカル スタディーズ グルタメート受容体組成物および方法

Also Published As

Publication number Publication date
EP0600278A2 (de) 1994-06-08
EP0600278B1 (de) 1999-07-21
EP0600278A3 (de) 1995-01-25
JP3353841B2 (ja) 2002-12-03
DE69325695T2 (de) 2000-03-09
JPH06157597A (ja) 1994-06-03

Similar Documents

Publication Publication Date Title
DE69325577D1 (de) Mn-gen und protein
DE69835020D1 (de) Plasmabrenner und verwendungsverfahren dieses plasmabrenners
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
DE69523791D1 (de) Peptid-mischung und produkte davon
DE69828407D1 (de) Zervikale-bandscheibe und rückgrat-stabilisierung
DE69431719D1 (de) Hybridisierung und sequenzierung von nukleinsäuren
DE69813233D1 (de) Hydrocyanierung von diolefinen und isomierung von nicht-konjugierten 2-alkyl-3-monoalkennitrilen
NO982878D0 (no) Trisykliske amider som er anvendbare for inhibering av G-proteinfunksjon og for behandling av proliferative sykdommer
DE69533188D1 (de) Stabilisierte transglutaminase und diese enthaltende enzymatische zubereitung
FI954978L (fi) Modifioidut proteiini- ja peptidilääkeaineet
ATA33697A (de) Faktor x-deletionsmutanten und analoge davon
DE69302234D1 (de) Menschliches Prohibitin und Prohibitin kodierende DNS
DE69615252D1 (de) Elektrodenstruktur und Heizkörper
DE59708905D1 (de) Injektionsformulierungen von avermectinen und milbemycinen
EP1015473A4 (de) Klonierung und expression von beta-app-c100 rezeptor (c100-r)
DE69333528D1 (de) D-n-carbamoylaminosaureamidohydrolase und hydantoinase
DE59507596D1 (de) Verbindung von Backrohr und Backrohr-Aufnahmerahmen
DE69329704D1 (de) Bilderzeugungsverfahrenn und Wärmefixierverfahren
DE69636841D1 (de) Entwicklungsgerät und Bilderzeugungsapparat
DE3684650D1 (de) Klonierung und charakterisierung des rinder-interleukin-2-gens.
DE69315260D1 (de) Thermoelektrisches Material und dieses Material anwendender Sensor
DE19681439T1 (de) Modifizierung von Polypeptidarzneimitteln zur Erhöhung des Elektrotransportflusses
DE69325695D1 (de) Protein und Gen des Glutamatrezeptors
DE69840094D1 (de) Beta-ketoacyl-acp-synthelase ii-enzym und dafür kodierendes gen
EP0724650A4 (de) Selektion und verwendung antiviraler peptide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition